INT J LAB HEMATOL:如何避免在儿科静脉穿刺?

2019-01-26 MedSci MedSci原创

在监测华法林抗凝患者时,国际标准化比(INR)的床旁检测(POC)检测已被广泛地与实验室产生的INR值进行比较,这使得病人可以更独立地进行自我监测。然而在儿科中仍然存在一定问题。 在本研究中,研究人员对449个连续的POC INR结果与实验室对从同一根手指采集的柠檬酸毛细管标本进行INR比较。并将结果进行统计学分析。 结果显示,CoaguChek XS和实验室平均INR值分别为2.85

在监测华法林抗凝患者时,国际标准化比(INR)的床旁检测(POC)检测已被广泛地与实验室产生的INR值进行比较,这使得病人可以更独立地进行自我监测。然而在儿科中仍然存在一定问题。

在本研究中,研究人员对449个连续的POC INR结果与实验室对从同一根手指采集的柠檬酸毛细管标本进行INR比较。并将结果进行统计学分析。

结果显示,CoaguChek XS和实验室平均INR值分别为2.85±1.19,2.63±1.11, r = 0.97时,两种方法的相关性较好。Bland-Altman分析显示0.22支持CoaguChek XS的偏见,有95%的极限协议−0.290.72passBablok方法比较得到的斜率为0.91 (y = 0.91x + 0.02)。研究发现89%的病例之间的方法的INR0.5,并且发现84%的一致性(κ= 0.69)

研究部门,将毛细管INR实验室结果与静脉标本的研究结果进行比较,毛细管标本的表现与静脉标本相当。因此,毛细管柠檬酸样品可以从用于在实验室进行POC INR确认。这可避免这种情况下静脉收集的创伤。

原始出处:

Vaughan K. Williams, Use of a capillary specimen in the laboratory to verify a pointofcare international normalized ratio: Avoidance of a venipuncture in a pediatric setting

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697841, encodeId=f220169e84131, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed May 15 15:09:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311934, encodeId=d0d913119344c, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317457, encodeId=9bd5131e4575e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581691, encodeId=cb1215816916b, content=<a href='/topic/show?id=c3049916553' target=_blank style='color:#2F92EE;'>#静脉穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99165, encryptionId=c3049916553, topicName=静脉穿刺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b816859588, createdName=ms1467340776200723, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359306, encodeId=ea8e3593062e, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Jan 26 22:36:38 CST 2019, time=2019-01-26, status=1, ipAttribution=)]
    2019-05-15 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697841, encodeId=f220169e84131, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed May 15 15:09:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311934, encodeId=d0d913119344c, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317457, encodeId=9bd5131e4575e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581691, encodeId=cb1215816916b, content=<a href='/topic/show?id=c3049916553' target=_blank style='color:#2F92EE;'>#静脉穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99165, encryptionId=c3049916553, topicName=静脉穿刺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b816859588, createdName=ms1467340776200723, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359306, encodeId=ea8e3593062e, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Jan 26 22:36:38 CST 2019, time=2019-01-26, status=1, ipAttribution=)]
    2019-01-28 rgjl
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697841, encodeId=f220169e84131, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed May 15 15:09:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311934, encodeId=d0d913119344c, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317457, encodeId=9bd5131e4575e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581691, encodeId=cb1215816916b, content=<a href='/topic/show?id=c3049916553' target=_blank style='color:#2F92EE;'>#静脉穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99165, encryptionId=c3049916553, topicName=静脉穿刺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b816859588, createdName=ms1467340776200723, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359306, encodeId=ea8e3593062e, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Jan 26 22:36:38 CST 2019, time=2019-01-26, status=1, ipAttribution=)]
    2019-01-28 fengyi812
  4. [GetPortalCommentsPageByObjectIdResponse(id=1697841, encodeId=f220169e84131, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed May 15 15:09:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311934, encodeId=d0d913119344c, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317457, encodeId=9bd5131e4575e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581691, encodeId=cb1215816916b, content=<a href='/topic/show?id=c3049916553' target=_blank style='color:#2F92EE;'>#静脉穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99165, encryptionId=c3049916553, topicName=静脉穿刺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b816859588, createdName=ms1467340776200723, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359306, encodeId=ea8e3593062e, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Jan 26 22:36:38 CST 2019, time=2019-01-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1697841, encodeId=f220169e84131, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed May 15 15:09:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311934, encodeId=d0d913119344c, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317457, encodeId=9bd5131e4575e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581691, encodeId=cb1215816916b, content=<a href='/topic/show?id=c3049916553' target=_blank style='color:#2F92EE;'>#静脉穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99165, encryptionId=c3049916553, topicName=静脉穿刺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b816859588, createdName=ms1467340776200723, createdTime=Mon Jan 28 13:09:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359306, encodeId=ea8e3593062e, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Sat Jan 26 22:36:38 CST 2019, time=2019-01-26, status=1, ipAttribution=)]
    2019-01-26 王秀

    学习了,涨知识了!

    0

相关资讯

护士必看!8种人群的静脉穿刺大法!

虽然静脉穿刺对于护士来说是需要掌握的基本功之一,但是有些时候碰到个别特殊情况,还是要多多学习和注意!

静脉穿刺有困难?看301医院亮“神器”

“一直以来,我都希望能有一个设备,像灯一样照在皮肤上便可清晰看见血管。”中国人民解放军总医院(下称301医院)内科临床部总护士长、心血管内科牵头护士长、主任护师李海燕这样诉说她的真切愿望。对于身处临床一线的护理人员而言,静脉穿刺可谓其“看家本领”。但随着我国生活水平的提高,尤其是人口老龄化趋势影响,肥胖患者、老年患者、病情疑难患者等日益增多,血管情况渐显复杂,如何准确找到静脉血管并精准注射,越

病例分享:万万没想到,这样的异物都能进血管!

患者行肠梗阻手术术后,为了进行长期肠内营养,值班医生决定行中心静脉穿刺,在穿刺置管过程中,由于值班医生中心静脉穿刺经验不足,未能按规范操作,结束操作后,未能找到金属引导导丝,反复检查后,怀疑金属导丝不慎滑落入患者血管内。

护理中护士必知十种静脉穿刺新方法

1、扎两根止血带法: 在肘关节上及腕关节内关穴处各扎一根止血带于肘窝部行静脉穿刺取血,比扎一根止血带效果好,对一些不能主动握拳配合的儿童,可代替握拳,同时局部血管充盈度满意。此法不仅适合儿童,也适合成人中因消瘦、血管不固定、不充盈、肌张力低下、衰竭及无力握拳患者。并在此基础上,扩大到手背(止血带一根扎在腕关节内关穴处,另一根扎在2~5指的第一节指节处)、足背(止血带一根扎在踝关节的内

经验|静脉穿刺十技巧,**有用!

一、扎两根止血带法在肘关节上及腕关节内关穴处各扎一根止血带于肘窝部行静脉穿刺取血,比扎一根止血带效果好,对一些不能主动握拳配合的儿童,可代替握拳,同时局部血管充盈度满意。此法不仅适合儿童,也适合成年人中因消瘦、血管不固定、不充盈、肌张力低下、衰竭及无力握拳患者。并在此基础上,扩大到手背(止血带一根扎在腕关节内关穴处,另一根扎在2~5指的第一节指节处)、足背(止血带一根扎在踝关节的内踝上6cm处

Ann Emerg Med:J-Tip可有效减少儿童静脉穿刺的疼痛

目的:J-Tip(国家医疗产品公司,Irvine,CA)用空气代替针将利多卡因推入皮肤。就目前为止,还没有针对J-Tip用于儿童静脉穿刺的调查研究。研究者决定将J-Tip与vapocoolant喷雾相比,比较两者在儿童静脉穿刺时减少的疼痛感。方法:招募1-6岁的儿童,将其随机分为3组:干预组(J-Tip),对照组(vapocoolant 喷雾),假干预组(vapocoolant 喷雾加一个空的J-